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Background: Respiratory syncytial virus (RSV) is a leading cause of hospital admission 
in young children. With several RSV vaccines candidates undergoing clinical trials, re-
cent estimates of RSV burden are required to provide a baseline for vaccine impact 
studies.
Objectives: To estimate the number of RSV- associated hospital admissions in children 
aged <5 years in England over a 5- year period from 2007 using ecological time series 
modelling of national hospital administrative data.
Patients/Methods: Multiple linear regression modelling of weekly time series of labo-
ratory surveillance data and Hospital Episode Statistics (HES) data was used to esti-
mate the number of hospital admissions due to major respiratory pathogens including 
RSV in children <5 years of age in England from mid- 2007 to mid- 2012, stratified by 
age group (<6 months, 6- 11 months, 1- 4 years) and primary diagnosis: bronchiolitis, 
pneumonia, unspecified lower respiratory tract infection (LRTI), bronchitis and upper 
respiratory tract infection (URTI).
Results: On average, 33 561 (95% confidence interval 30 429- 38 489) RSV- associated 
hospital admissions in children <5 years of age occurred annually from 2007 to 2012. 
Average annual admission rates were 35.1 (95% CI: 32.9- 38.9) per 1000 children aged 
<1 year and 5.31 (95% CI: 4.5- 6.6) per 1000 children aged 1- 4 years. About 84% (95% 
CI: 81- 91%) of RSV- associated admissions were for LRTI. The diagnosis- specific bur-
den of RSV- associated admissions differed significantly by age group.
Conclusions: RSV remains a significant cause of hospital admissions in young children 
in England. Individual- level analysis of RSV- associated admissions is required to fully 
describe the burden by age and risk group and identify optimal prevention strategies.
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1  | BACKGROUND
Respiratory syncytial virus (RSV) is a major cause of respiratory tract 
infections (RTI) worldwide.1 In older children and adults, RSV infection 
often leads to mild upper respiratory tract infection (URTI). However, 
in infants and young children, RSV is an important cause of severe re-
spiratory infection, particularly bronchiolitis, which may require hospi-
tal admission.2 With a number of RSV vaccine candidates now in phase 
2 and 3 clinical trials, it is essential to have accurate estimates of the 
hospital burden of RSV by age and risk group in order to determine the 
potential benefits of a future vaccine programme.3
Calculating the national burden of disease due to RSV is not 
straightforward. A reliable diagnosis of RSV infection relies on the de-
tection of RSV in respiratory secretions, but only a minority of children 
hospitalised with an acute respiratory infection will undergo labora-
tory testing to identify the causal pathogen.4 The vast majority of re-
spiratory infections are therefore recorded in hospital admission data 
under non- specific diagnosis such as unspecified pneumonia or bron-
chiolitis. Hospital admission data alone can therefore not be used to 
accurately calculate the burden of RSV in secondary care.
Respiratory pathogens have varying temporal patterns which can 
be observed using laboratory surveillance data. Statistical models 
which utilise the seasonal variation in laboratory reports by patho-
gen can be constructed to attribute hospital admissions to different 
viruses.4,5 This method of estimating the hospital burden of RSV has 
previously been used in the UK; however, the most recent study only 
considers data up to 2009.4–6 Surveillance of respiratory viruses in-
cluding RSV has been strengthened in England since the 2009 influ-
enza A (H1N1) pandemic, with more widespread use of laboratory 
confirmation for respiratory viruses with PCR methods, and a greater 
degree of reporting to national surveillance schemes.7 In addition, a 
recent study in the UK demonstrates that hospital admission due to 
bronchiolitis is increasing over time.8 These developments empha-
sise the need for more recent estimates of RSV- associated hospital 
admissions as previous estimates may not reflect the current burden 
of disease.
The aim of this work was to estimate the number of hospital ad-
missions attributable to RSV in children <5 years of age in England in 
the period from mid- 2007 to mid- 2012 using ecological time series 
modelling of national laboratory surveillance and hospital administra-
tive data.
2  | METHODS
2.1 | Data sources
2.1.1 | National laboratory reports
The Second Generation Surveillance System (SGSS)—formerly 
LabBase2—is a microbiology laboratory surveillance database at 
the Centre for Infectious Disease Surveillance and Control (CIDSC) 
at Public Health England (PHE), the national centre responsible for 
infectious disease surveillance, prevention and control. Positive test 
results for microorganisms recorded in SGSS are collected from local 
pathology systems transmitted from PHE, NHS and private microbiol-
ogy laboratories in England.9 All clinically significant microorganisms 
should be reported, although no guidelines for the judgement of clinical 
significance are defined. Weekly laboratory reports of samples posi-
tive for RSV, influenza A, influenza B, rhinovirus, parainfluenza, human 
metapneumovirus (hMPV), adenovirus, Streptococcus pneumoniae, 
Mycoplasma pneumoniae and Haemophilus influenza in children <5 years 
of age (at the time of the sample) in England from calendar week 27 
(mid- July) in 2007 to calendar week 28 (mid- July) in 2012 were ex-
tracted. If individuals had multiple positive samples for the same virus 
within a two- week period, only one record was included in this analy-
sis—this was to avoid multiple tests in the same individual within the 
same infection episode being counted as separate infections.
2.1.2 | Hospital Episode Statistics (HES)
The Hospital Episode Statistics (HES) admitted patient care database, 
held by the Health and Social Care Information Centre (HSCIC), con-
tains routinely collected data on all admissions to all NHS hospitals in 
England. Records include clinical, geographical and administrative in-
formation including admission and discharge dates, on every patient. 
In this analysis, an admission refers to a single HES spell—from admis-
sion to discharge in one hospital.
Diagnoses are recorded in HES using International Classification of 
Diseases 10th Revision (ICD- 10) codes, with up to 20 diagnosis codes 
allowed per HES episode. Each admission is allocated a primary diag-
nosis which is the main reason for the length of stay in hospital. All 
admissions with a primary diagnosis of ICD- 10 codes for bronchiolitis 
(ICD- 10 J21), pneumonia (J12- 18), unspecified lower respiratory tract 
infection (LRTI) (J22), bronchitis (J20) and upper respiratory tract in-
fection (URTI) (J00- 06) in children <5 years of age (at admission) in 
England from calendar week 27 in 2007 to calendar week 26 in 2012 
were included in the study. Calendar weeks were defined as blocks of 
7 days beginning on 1st January each year, with week 52 allowed to 
have more than 7 days. Only the primary diagnosis was included to 
avoid double counting of admissions which may have two or more of 
these diagnoses. HES data were not available for 2013 onwards. The 
weekly number of hospital admissions was stratified into three groups: 
<6 months, 6- 11 months and 1- 4 years.
2.2 | Statistical analysis
In this study, we use the observed temporal variation in weekly labora-
tory reports of potential causative pathogens to estimate the number 
of RTI hospital admissions that could be attributed to RSV, building on 
methods applied in previous modelling studies.4,10,11 Separate models 
were developed for each primary diagnosis, using the weekly num-
ber of hospital admissions in children <5 years of age in England for 
each respective diagnosis as the dependent variable. For each diag-
nosis, separate models were constructed by age group (<6 months, 
6- 11 months, 1- 4 years).
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Multiple linear regression models were used to estimate the 
number of hospital admissions due to RSV from HES data coded as 
acute bronchiolitis, pneumonia, unspecified LRTI, bronchitis and URTI. 
These models have been used in similar studies.4,10,12,13 All models 
used the weekly number of laboratory- confirmed episodes in children 
<5 years of age in England for the following pathogens as the inde-
pendent variables: RSV, influenza A, influenza B, rhinovirus, parainflu-
enza, human metapneumovirus (hMPV) and adenovirus. The weekly 
number of laboratory- confirmed episodes of Streptococcus pneumo-
niae, Mycoplasma pneumoniae and Haemophilus influenza in children 
<5 years of age in England was also included as independent variables 
in the models for pneumonia and unspecified LRTI. All variables were 
first included in the models, then those with negative coefficients 
removed (in order of decreasing significance) due to biological im-
plausibility (pathogens cannot cause a negative number of hospital 
admissions), followed by those that did not contribute significantly to 
the model (F- test P>.05). Interactions between all pathogens in the 
final model were investigated (P≤.01 was considered significant) due 
to the potential for co- circulation of pathogens. Interactions between 
pathogens in the final model and an indicator variable taking the value 
0 for the pre- pandemic period (before week 20 2009) and 1 for the 
pandemic and post- pandemic period were investigated to account 
for potential changes in testing practice following the 2009 influenza 
pandemic (P≤.01 was considered significant).
Final estimates of the number of hospital admissions attribut-
able to each pathogen (including 95% confidence intervals (CIs)) 
were calculated by multiplying the coefficient from the final model 
by the total number of weekly laboratory- confirmed episodes for 
each relevant pathogen. The total number of hospital admissions 
for all children <5 years old was calculated as the sum of the num-
ber of hospital admissions calculated in each age group for each 
pathogen.
Admission rates were calculated using ONS mid- year population 
estimates for England by age group (<1 year, 1- 4 years).14,15 The av-
erage of ONS mid- year population estimates for 2007 and 2008 was 
used as the denominator for the 2007/2008 epidemiological year and 
the average of ONS mid- year population estimates for 2008 and 2009 
used for the 2008/2009 epidemiological year, etc.
3  | RESULTS
3.1 | Seasonality of laboratory reports and hospital 
admissions
The temporal variation in laboratory reports by pathogen is shown 
in Figure 1. The temporal trends in hospital admissions for children 
<5 years old in England with a primary diagnosis of bronchiolitis, pneu-
monia, bronchitis, unspecified LRTI or URTI are shown in Figure 2. 
Hospital admissions with a primary diagnosis of bronchiolitis were 
markedly seasonal and mirror the pattern of laboratory- confirmed 
RSV infections. Hospital admissions with a primary diagnosis of pneu-
monia had a very similar seasonal pattern to hospital admissions with 
a primary diagnosis of unspecified LRTI, with peaks also occurring at 
the same time as the peaks in laboratory- confirmed RSV infections in 
SGSS each year (Figure 2).
3.2 | Estimated RSV- associated hospital admissions
3.2.1 | All RTI admissions
Of the 121 968 hospital admissions with a primary diagnosis of 
bronchiolitis, pneumonia, bronchitis, unspecified LRTI or URTI that 
occurred annually in children <5 years of age from mid- 2007 to mid- 
2012, we estimate that 28% (33 561/121 968, 95% CI: 25- 32%) 
were due to RSV. Of RSV- associated RTI hospital admissions, 48% 
(16 202/33 561, 95% CI: 46- 52%) were in children <6 months of age, 
21% (7108/33 561, 95% CI: 19- 25%) were in children 6- 11 months of 
age, and 31% (10 251/33 561, 95% CI: 26- 38%) were in children aged 
1- 4 years (Table 1). The majority, 84% (28 111/33 561, 95% CI: 81- 
91%), of RSV- associated RTI hospital admissions were for LRTI. About 
65% (21 418/33 561, 95% CI: 62- 70%) of RSV- associated hospital 
admissions were coded as bronchiolitis (Tables 1 and 2).
On average, the estimated admission rate of any RSV- associated 
RTI hospital admission was 35.1 (95% CI: 32.9- 38.9) per 1000 chil-
dren <1 year of age and 5.31 (95% CI: 4.5- 6.6) per 1000 children 
1- 4 years of age, per epidemiological year (Table 3). Estimated rates 
of RSV- associated hospital admissions were, on average, higher in 
<1- year- olds for all diagnoses except unspecified LRTI, where admis-
sion rates in 1- to 4- year- olds were higher (Table 3). All LRTI admission 
rates increased in both age groups over time, peaking in 2010/2011 
(the RSV season following the 2009 influenza A (H1N1) pandemic, 
which was an intense seasonal influenza season dominated by A/
H1N1pdm09) and with a slight decrease in 2011/2012 for all diagno-
ses except pneumonia. Admissions for URTI decreased over the study 
period, particularly in the 1- 4 years of age group which saw a 70% 
decrease from 2.9 (95% CI: 2.5- 3.4) admissions per 1000 children in 
2007/2008 to 0.9 (95% CI: 0.3- 2.1) per 1000 children in 2011/2012. 
The percentage of weekly hospital admissions attributed to RSV varied 
by calendar week for all primary diagnoses and age groups (Figure 3).
3.2.2 | LRTI admissions: bronchiolitis, pneumonia, 
bronchitis and unspecified LRTI
Overall, 53% (28 111/53 514, 95% CI: 51- 57%) of LRTI admissions 
in children <5 years of age could be attributed to RSV, and 54% 
(15 260/28 111, 95% CI: 52- 58%) of RSV- associated LRTIs were in 
infants <6 months old (Table 1). Of RSV- associated LRTI admissions, 
78% (21 830/28 111, 95% CI: 74- 83%) were coded as bronchiolitis, 
13% (3766/28 111, 95% CI: 12- 15%) were coded as unspecified LRTI, 
8% (2346/28 111, 95% CI: 7- 9%) were coded as pneumonia, and <1% 
(169/28 111) were coded as bronchitis.
There was an annual average of 27 969 hospital admissions with 
a primary diagnosis of bronchiolitis in children <5 years of age in 
England from 2007 to 2012. We estimate that approximately 78% 
(21 830/27 969, 95% CI: 75- 83%) of these were due to RSV (Tables 1 
and 2). There were differences by age, with approximately 82% 
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(14 962/18 246, 95% CI: 79- 87%) of all bronchiolitis admissions in 
children aged <6 months attributable to RSV, 70% (5319/7652, 95% 
CI: 66- 75%) of bronchiolitis admissions in children aged 6- 11 months 
attributable to RSV and 75% (1549/2071, 95% CI: 71- 79%) of bron-
chiolitis admissions in children aged 1- 4 years attributable to RSV 
(Table 2). During the period from calendar week 46 to week 2, over 
90% of bronchiolitis admissions in children aged <6 months and over 
80% in children aged 6- 11 months and 1- 4 years were attributable to 
RSV each week (Figure 3). The other explanatory pathogens for bron-
chiolitis admissions were parainfluenza, hMPV and rhinovirus, with 
differences in causal pathogens by age (see Supplementary Data).
There was an annual average of 9537 hospital admissions with 
a primary diagnosis of pneumonia in children <5 years of age in 
England from 2007 to 2012. We estimate that approximately 25% 
(2346/9537, 95% CI: 22- 27%) of these were due to RSV (Table 1). 
There were differences by age, with approximately 26% (1923/7503, 
F IGURE  1 Weekly number of 
laboratory- confirmed cases of major 
respiratory viruses recorded in SGSS for 
children <5 y of age, over time
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95% CI: 23- 28%) of pneumonia admissions in children aged 1- 4 years 
attributable to RSV compared to 19% in children aged <6 months 
(138/739, 95% CI: 14- 28%). The other main explanatory pathogens 
for hospital admissions with a primary diagnosis of pneumonia in chil-
dren <5 years of age were S. pneumoniae, hMPV, parainfluenza, influ-
enza A and rhinovirus, with differences in causal pathogens by age.
There was an annual average of 547 hospital admissions with a 
primary diagnosis of acute bronchitis in children <5 years of age in 
England from 2007 to 2012. We estimate that approximately 31% 
(169/547, 95% CI: 23- 42%) of these were due to RSV (Table 1). There 
were differences by age, with approximately 56% (89/159, 95% CI: 
48- 71%) of bronchitis hospital admissions in children <6 months 
of age attributed to RSV, compared to only 14% (39/276, 95% CI: 
8- 20%) in children aged 1- 4 years (Table 2). The other explanatory 
pathogens for hospital admissions with a primary diagnosis of bron-
chitis were parainfluenza and adenovirus in children aged 1- 4 years 
only.
There was an annual average of 15 461 hospital admissions with 
a primary diagnosis of unspecified LRTI in children <5 years of age in 
England from 2007 to 2012. We estimate that approximately 24% 
F IGURE  2 Weekly number of hospital 
admissions in children <5 y of age in 
England with any diagnosis of URTI, 
bronchiolitis, pneumonia, bronchitis or 
unspecified LRTI. Weekly number of 
laboratory- confirmed RSV infections in 
children <5 y of age in England (SGSS) 
shown in orange
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TABLE  1 Average annual number of hospital admissions in children <5 y of age in England: total per primary diagnosis and number 
estimated to be attributed to RSV by the final models, stratified by age group (<6 mo, 6- 11 mo, 1- 4 y)
Primary diagnosis
Annual number of hospital admissions (95% CI)
<6 mo 6- 11 mo 1- 4 y Total
Bronchiolitis
Total 18 246 7652 2071 27 969
RSV- associated 14 962 (14 396- 15 942) 5319 (5066- 5775) 1549 (1467- 1631) 21 830 (20 929- 23 348)
Pneumonia
Total 739 1294 7503 9537
RSV- associated 138 (101- 158) 285 (245- 324) 1923 (1 718- 2 128) 2346 (2064- 2610)
Bronchitis
Total 159 113 276 547
RSV- associated 89 (76- 113) 41 (29- 62) 39 (23- 55) 169 (128- 230)
Unspecified LRTI
Total 1224 2546 11 690 15 461
RSV- associated 71 (37- 104) 429 (322- 619) 3266 (3007- 3525) 3766 (3366- 4248)
URTI
Total 8868 12 737 46 850 68 455
RSV- associated 942 (802- 1082) 1034 (742- 1559) 3474 (2398- 5412) 5450 (3222- 8053)
Total 29 236 24 342 68 390 121 968
Total RSV- associated 16 202 (15 412- 17 399) 7108 (6404- 8339) 10 251 (8613- 12 751) 33 561(30 429- 38 489)
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(3766/15 461, 95% CI: 22- 27%) of these were due to RSV. There 
were differences by age, with approximately 28% (3266/11 690, 95% 
CI: 26- 30%) of unspecified LRTI hospital admissions in children aged 
1- 4 years of age attributed to RSV, compared to only approximately 
6% (71/1224, 95% CI: 3- 8%) in children <6 months of age (Table 2). 
The other main explanatory pathogens for hospital admissions with a 
primary diagnosis of unspecified LRTI in children <5 years of age were 
adenovirus, S. pneumoniae, hMPV, parainfluenza, rhinovirus and influ-
enza A, with differences in causal pathogens by age.
3.2.3 | URTI admissions
From 2007 to 2012, there was an annual average of 68 455 hospital 
admissions with a primary diagnosis of URTI in children <5 years of 
age in England. We estimate that approximately 8% (5450/68 455, 
95% CI: 5- 12%) of these were due to RSV (Table 1). There were no 
significant differences in the percentage of URTI admissions attribut-
able to RSV by age group, although a slightly higher percentage of 
admissions in children <6 months of age were attributed to RSV (11%, 
942/8868, 95% CI: 9- 12%). The other explanatory pathogens for hos-
pital admissions with a primary diagnosis of URTI were influenza A, 
parainfluenza and adenovirus.
The number of hospital admissions attributed to each pathogen in 
each final model is shown in Table S1.
4  | DISCUSSION
Every year, approximately 33 561 (95% CI: 30 429- 38 489) hospital 
admissions for RTIs in children <5 years of age from 2007 to 2012 
could be attributed to RSV. This represents annual RSV- associated 
RTI admission rates of 35.1 (95% CI: 32.9- 38.9) per 1000 chil-
dren <1 year of age and 5.31 (95% CI: 4.5- 6.6) per 1000 children 
1- 4 years of age. The vast majority of these RSV- associated admis-
sions (84%, 95% CI: 81- 91%) were coded as LRTIs. Of the RSV- 
associated LRTIs, nearly half were in children aged <6 months (48%, 
95% CI: 46- 52%). Approximately 82% (95% CI: 79- 87%) of hospital 
admissions for bronchiolitis in children aged <6 months could be 
attributed to RSV.
Our study is the first to determine burden of RSV- associated 
respiratory hospital admissions in children in England according to 
primary diagnosis and age group. Our study uses smaller age group-
ings than previous studies to more precisely reflect the differences in 
RSV- associated illness by age. Our study is also the first to estimate 
TABLE  3 Estimated admission rates of RSV- associated hospital admissions per 1000 children <5 y of age in England.
Estimated admission rate of RSV- associated hospital admissions (per 1000) 
(95% CI)
Age group 2007/8 2008/9 2009/10 2010/11 2011/12 Average
URTI <1 y 3.00 (2.50- 3.50) 3.41 (2.84- 3.41) 2.73 (2.03- 4.00) 3.00 (2.23- 4.39) 2.59 (1.92- 3.79) 2.95 (2.31- 3.93)
1- 4 y 2.94 (2.49- 3.38) 3.29 (2.79- 3.29) 0.95 (0.35- 2.27) 1.04 (0.38- 2.48) 0.90 (0.33- 2.14) 1.82 (1.27- 2.81)
Bronchiolitis <1 y 27.1 (26.2- 28.1) 30.8 (29.8- 31.9) 30.5 (29.2- 33.4) 33.6 (32.1- 36.7) 29.0 (27.7- 31.7) 30.2 (29.0- 32.3)
1- 4 y 0.64 (0.60- 0.67) 0.72 (0.68- 0.76) 0.87 (0.82- 0.91) 0.94 (0.89- 0.99) 0.82 (0.77- 0.86) 0.90 (0.75- 0.84)
Unspecified 
LRTI
<1 y 0.40 (0.24- 0.57) 0.46 (0.27- 0.65) 0.93 (0.70- 1.36) 1.03 (0.78- 1.50) 0.89 (0.67- 1.29) 0.74 (0.53- 1.07)
1- 4 y 1.34 (1.24- 1.45) 1.52 (1.40- 1.64) 1.82 (1.68- 1.97) 1.99 (1.83- 2.15) 1.72 (1.58- 1.86) 1.68 (1.55- 1.81)
Pneumonia <1 y 0.54 (0.45- 0.63) 0.62 (0.52- 0.72) 0.65 (0.53- 0.84) 0.72 (0.58- 0.93) 2.69 (2.28- 3.16) 1.04 (0.87- 1.26)
1- 4 y 0.79 (0.71- 0.88) 0.89 (0.81- 0.99) 1.07 (0.96- 1.19) 1.17 (1.05- 1.30) 1.01 (0.91- 1.12) 0.99 (0.88- 1.09)
Bronchitis <1 y 0.21 (0.18- 0.24) 0.24 (0.20- 0.27) 0.17 (0.13- 0.26) 0.19 (0.15- 0.29) 0.17 (0.13- 0.25) 0.20 (0.16- 0.26)
1- 4 y 0.02 (0.01- 0.02) 0.02 (0.01- 0.03) 0.02 (0.01- 0.03) 0.02 (0.01- 0.03) 0.02 (0.01- 0.03) 0.02 (0.01- 0.03)
Total <1 y 31.3 (29.5- 33.0) 35.6 (33.6- 37.6) 35.0 (32.6- 39.8) 38.5 (35.9- 43.8) 35.5 (32.7- 40.1) 35.1 (32.9- 38.9)
1- 4 y 5.73 (5.05- 6.40) 6.43 (5.67- 7.20) 4.74 (3.82- 6.37) 5.17 (4.17- 6.95) 4.47 (3.61- 6.01) 5.31 (4.46- 6.59)
TABLE  2 Total RTI hospital admissions estimated to be due to RSV by the final models, stratified by age group (<6 mo, 6- 11 mo, 1- 4 y) and 
primary diagnosis, as a percentage of the total hospital admissions for the respective primary diagnosis
Primary diagnosis
Percentage of annual hospital admissions (per primary diagnosis) attributed to RSV (95% CI)
<6 mo 6- 11 mo 1- 4 y Total
Bronchiolitis 82% (79- 87%) 70% (66- 75%) 75% (71- 79%) 78% (75- 83%)
Pneumonia 19% (14- 28%) 22% (19- 25%) 26% (23- 28%) 25% (22- 27%)
Bronchitis 56% (48- 71%) 37% (28- 55%) 14% (8- 20%) 31% (23- 42%)
Unspecified LRTI 6% (3- 8%) 17% (13- 24%) 28% (26- 30%) 24% (22- 27%)
URTI 11% (9- 12%) 8% (6- 12%) 7% (5- 12%) 8% (5- 12%)
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the burden of RSV in England in the post- 2009 influenza A (H1N1) 
pandemic era. However, the methods used here do have potential lim-
itations. Firstly, our models assume that the temporal variation in lab-
oratory reports of the causative agents is an accurate representation 
of their relative incidence over time. The results will be biased if this 
is not the case (ie due to seasonal changes in laboratory testing or re-
porting). Secondly, there may be other reasons for temporal variations 
that are not accounted for in this analysis (eg meteorological variables), 
and it is possible that some hospital admissions could be attributed to 
other pathogens with similar temporal patterns to those that we have 
considered (eg other bacterial pathogens).10 Thirdly, it is possible that 
age- related differences in testing practices may have impacted our 
quantitative estimates—particularly those for influenza- associated ad-
missions. However, that our results demonstrate a significantly higher 
burden of RSV- associated hospital admissions in young children com-
pared to other respiratory pathogens, including influenza, is consis-
tent with the results of previous studies.16–18 Finally, as we restricted 
hospital admissions to those with a primary diagnosis of URTI or LRTI, 
our results are likely to be an underestimate of the true burden of RSV- 
associated hospital admissions.
Previous estimates of RSV burden in secondary care in England 
range from 26 500 to 29 160 RSV- associated hospital admissions 
per year in children <5 years of age—all lower than our estimate 
of 33 561 (95% CI: 30 429- 38 489) RSV- associated admissions, 
which is probably due to those studies considering earlier time peri-
ods.4–6,10 Our study found a steady, general increase in the admission 
rates of RSV- associated LRTI hospital admissions from 2007/2008 
to 2011/2012, peaking during the 2010/2011 season. There are a 
number of potential explanations for this increase over time. Our 
models are sensitive to the number of positive laboratory tests; 
therefore, our results could be affected by a change in the relative 
sensitivity or specificity of the assays for the different pathogens 
over time, although the majority of laboratories have been using 
RT- PCR for most of the study period. However, from 1999 to 2010, 
there has been an increase of 28% in emergency hospital admissions 
in children <5 years of age, particularly admissions for acute illness, 
and the annual number of hospital admissions due to bronchiolitis 
in young children in the UK has also increased sevenfold between 
1979 and 2011.8,19 This evidence suggests that the increase is not 
due to an increase in the severity of infection, nor the virulence of 
RSV in the age group, because paediatric intensive care admission 
rates have changed little from 2004 to 2012.8 Instead, these trends 
are likely due to a general increase in hospital admission, potentially 
due to hospital admission thresholds being lowered (particularly in 
the younger infants) or failure to manage these acute illnesses in the 
community care setting.20
Our study found a high burden of RSV- associated hospital ad-
missions in children <6 months of age, a group well documented as 
being at high risk of RSV- associated hospital admission.21 However, 
our study also found a high number of RSV- associated pneumonia and 
unspecified LRTI admissions in children aged 1- 4 years. RSV was the 
pathogen associated with the highest number of admissions for all 
types of LRTI in all age groups compared to the other pathogens, ex-
cept for pneumonia and unspecified LRTI in children aged <6 months 
F IGURE  3 Percentage of total weekly hospital admissions due to RSV for each primary diagnosis, by age group
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and 6- 11 months. It is therefore possible that RSV- associated hospi-
tal admissions are more likely to be coded as bronchiolitis in young 
infants, but as pneumonia or unspecified LRTI in children older than 
one year.
As this analysis is at the population level, it is not possible to in-
vestigate individual- level risk factors for RSV- associated hospital ad-
mission or additional outcomes indicating the severity of illness such 
as length of stay or admission to paediatric intensive care. Individual- 
level analysis of RSV- associated hospital admission could be achieved 
through linkage of laboratory surveillance data and hospital admis-
sions data, as demonstrated in Western Australia.22
In conclusion, RSV is a significant cause of hospital admissions for 
LRTI in children <5 years of age in England. Large- scale individual- 
level analysis of RSV- associated hospital admissions in young children 
in secondary care in England is required to compare the severity of 
cases by age. This work provides a baseline for vaccine impact studies 
if such vaccines are introduced into the UK immunisation programme 
in the future.
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